Auckland Clinical Studies

Auckland 2105

0 studies enrolling now · 16 studies all time

What they study most

Autoimmune Diseases, Celiac, Celiac Disease, Chronic Hepatitis B, Chronic Hepatitis C, Digestive System Disease, Down Syndrome, Gastrointestinal Disease, Gluten Sensitivity, HCC, HCV Infection, Hepatitis C

Studies at this site

• GNOS-PV02 Personalized Neoantigen Vaccine, INO-9012 and Pembrolizumab in Subjects With Advanced HCC — Running, not enrolling
• A Study of ABI-H0731 + Nucleos(t)Ide as Finite Treatment for Chronic Hepatitis B Patients — Stopped early
• A Registry for Adolescent and Pediatric Participants Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials — Stopped early
• A Study of ABI-H2158-containing Regimens in Participants With Chronic Hepatitis B Virus Infection — Stopped early
• A Study of ABI-H2158 in Healthy Volunteers and Patients With Chronic Hepatitis B — Completed
• Pharmacokinetics of Voxilaprevir in Adults With Normal Hepatic Function and Moderate or Severe Hepatic Impairment — Completed
• Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Genotype 1 HCV Infection — Completed
• Pharmacokinetics of Entospletinib in Adults With Normal and Impaired Liver Function — Completed
• Safety and Efficacy of GS-4774 in Combination With Tenofovir Disoproxil Fumarate (TDF) for the Treatment of Participants With Chronic Hepatitis B (CHB) and Who Are Currently Not on Treatment — Completed
• A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD) — Status unconfirmed
• Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH) — Completed
• A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B — Completed
• A Study of RG1662 in Adults and Adolescents With Down Syndrome (CLEMATIS) — Completed
• A Study of Faldaprevir, TD-6450 and Other Antivirals in Participants With Genotype 1b Hepatitis C Virus Infection — Completed
• A Screening Protocol to Assess Adults and Adolescents With Down Syndrome for Eligibility For Upcoming Study of RG1662 (Study BP27832) — Completed
• Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant — Completed